Cmv Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-04-14
Clinical Trial Update: Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002) [Phase 3]
Phase 3 trial comparing letermovir to valganciclovir for prevention of CMV disease in kidney transplant recipients has completed with result…